Monday Jul 21
InterMune EVP Paul D. Arata Unloads 2,382 Shares
InterMune EVP Paul D. Arata sold 2,382 shares of InterMune stock in a transaction dated Thursday, July 17th.
Monday Jul 21
The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
Stars aligning for U.S. Patients Suffering from Idiopathic Pulmonary Fibrosis
The stars are seemingly aligning for patients with Idiopathic Pulmonary Fibrosis and patient groups like the Coalition for Pulmonary Fibrosis , who are preparing for good news for a change.
InterMune EVP Jonathan A. Leff Sells 35,000 Shares
InterMune EVP Jonathan A. Leff sold 35,000 shares of the company's stock in a transaction dated Tuesday, July 15th.
InterMune, Inc. Grabs FDA Breakthough Therapy Designation For IPF Drug Pirfenidone
This designation is reserved for drugs that are intended to treat a serious or life threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints.
IWM, FNY: Big ETF Outflows
Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the iShares Russell 2000 ETF , where 23,200,000 units were destroyed, or a 9.7% decrease week over week.
PDUFA date set for pirfenidone NDA
The FDA acknowledges the receipt of Intermune's resubmitted NDA for pirfenidone.
Them who has gets
Demonstrating the value of convertible debt, certain holders of InterMune's Convertible Senior Notes exchange the debt for shares in several private transactions.